LAWYER
LOCATIONS
CULTURE
PRO BONO
DIVERSITY
ALUMNI
CAREERS
繁體
简体
English
Home
/
News & Insights
/
Advances Toward New Antidepressants Beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with Dual 5-HT1A Receptor Antagonism/ SSRI Activities. Part 4
Advances Toward New Antidepressants Beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with Dual 5-HT1A Receptor Antagonism/ SSRI Activities. Part 4
January 01, 2004
Subscribe to Dechert Updates
Subscribe
Related News & Insights
Resources relating to
Advances Toward New Antidepressants Beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with Dual 5-HT1A Receptor Antagonism/ SSRI Activities. Part 4
